Lack of N1L gene expression results in a significant decrease of vaccinia virus replication in mouse brain
- PMID: 15659810
- DOI: 10.1196/annals.1329.037
Lack of N1L gene expression results in a significant decrease of vaccinia virus replication in mouse brain
Abstract
Vaccinia virus encodes secretory proteins termed virokines. One of the major virokines encoded by the N1L open reading frame is the 13.8 kDa protein. A recombinant virus, termed vGK5, lacking this protein when injected intracranially into mice, has one of the highest levels of in vivo attenuation achieved by deletion of any single open reading frame of vaccinia virus. Here we show that the 13.8 kDa protein significantly enhances viral replication within brain tissue; however, analysis of histology, neutrophil infiltrate, and nitric oxide synthase activity of brain tissue shows no significant differences between wild-type vaccinia virus and vGK5. Since there is poor growth of vGK5 virus in the brain, the possibility of postvaccinial encephalitis is significantly diminished. Mice injected with vGK5 became resistant to the lethal effects of vaccinia virus, indicating that vGK5 is immunogenic in the brain without being virulent and therefore is a vaccine candidate. This suggests that should vGK5 reach the brain it will not replicate efficiently but still serve as a live vaccine.
Similar articles
-
The vaccinia virus N1L ORF may encode a multifunctional protein possibly targeting different kinases, one of which influences ATP levels in vivo.Ann N Y Acad Sci. 2005 Nov;1056:87-99. doi: 10.1196/annals.1352.006. Ann N Y Acad Sci. 2005. PMID: 16387679
-
The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response.Virology. 2005 Mar 15;333(2):263-70. doi: 10.1016/j.virol.2005.01.006. Virology. 2005. PMID: 15721360
-
The cowpox virus-encoded homolog of the vaccinia virus complement control protein is an inflammation modulatory protein.Virology. 1997 Mar 3;229(1):126-33. doi: 10.1006/viro.1996.8396. Virology. 1997. PMID: 9123854
-
[Mapping vaccinia virus genes].Mol Biol (Mosk). 1993 Mar-Apr;27(2):269-89. Mol Biol (Mosk). 1993. PMID: 8487758 Review. Russian.
-
Virokines: mediators of virus-host interaction and future immunomodulators in medicine.Arch Immunol Ther Exp (Warsz). 1999;47(3):135-8. Arch Immunol Ther Exp (Warsz). 1999. PMID: 10470439 Review.
Cited by
-
Pathogeneses of respiratory infections with virulent and attenuated vaccinia viruses.Virol J. 2007 Feb 27;4:22. doi: 10.1186/1743-422X-4-22. Virol J. 2007. PMID: 17326843 Free PMC article.
-
Robust intrapulmonary CD8 T cell responses and protection with an attenuated N1L deleted vaccinia virus.PLoS One. 2008 Oct 2;3(10):e3323. doi: 10.1371/journal.pone.0003323. PLoS One. 2008. PMID: 18830408 Free PMC article.
-
A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9.Mol Ther Methods Clin Dev. 2015 Sep 16;2:15035. doi: 10.1038/mtm.2015.35. eCollection 2015. Mol Ther Methods Clin Dev. 2015. PMID: 26417609 Free PMC article.
-
Cowpox virus expresses a novel ankyrin repeat NF-kappaB inhibitor that controls inflammatory cell influx into virus-infected tissues and is critical for virus pathogenesis.J Virol. 2009 Sep;83(18):9223-36. doi: 10.1128/JVI.00861-09. Epub 2009 Jul 1. J Virol. 2009. PMID: 19570875 Free PMC article.
-
Anti-HIV, anti-poxvirus, and anti-SARS activity of a nontoxic, acidic plant extract from the Trifollium species Secomet-V/anti-vac suggests that it contains a novel broad-spectrum antiviral.Ann N Y Acad Sci. 2005 Nov;1056(1):293-302. doi: 10.1196/annals.1352.014. Ann N Y Acad Sci. 2005. PMID: 16387696 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
